Schedule I standing undoubtedly raises the level of complexity for virtually any investigate study. For instance, all researchers—irrespective of whether preclinical or clinical—must receive Program I investigate registrations. 21 CFR portion 1301.18. By contrast, researchers who have DEA Practitioner registrations in Schedules II–V (which mo